Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver.

Biochim Biophys Acta

Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA, United States. Electronic address:

Published: September 2016

The constitutive androstane receptor (CAR; NR1I3) is a member of the nuclear receptor superfamily that functions as a xenosensor, serving to regulate xenobiotic detoxification, lipid homeostasis and energy metabolism. CAR activation is also a key contributor to the development of chemical hepatocarcinogenesis in mice. The underlying pathways affected by CAR in these processes are complex and not fully elucidated. MicroRNAs (miRNAs) have emerged as critical modulators of gene expression and appear to impact many cellular pathways, including those involved in chemical detoxification and liver tumor development. In this study, we used deep sequencing approaches with an Illumina HiSeq platform to differentially profile microRNA expression patterns in livers from wild type C57BL/6J mice following CAR activation with the mouse CAR-specific ligand activator, 1,4-bis-[2-(3,5,-dichloropyridyloxy)] benzene (TCPOBOP). Bioinformatic analyses and pathway evaluations were performed leading to the identification of 51 miRNAs whose expression levels were significantly altered by TCPOBOP treatment, including mmu-miR-802-5p and miR-485-3p. Ingenuity Pathway Analysis of the differentially expressed microRNAs revealed altered effector pathways, including those involved in liver cell growth and proliferation. A functional network among CAR targeted genes and the affected microRNAs was constructed to illustrate how CAR modulation of microRNA expression may potentially mediate its biological role in mouse hepatocyte proliferation. This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975621PMC
http://dx.doi.org/10.1016/j.bbagrm.2016.04.002DOI Listing

Publication Analysis

Top Keywords

constitutive androstane
8
androstane receptor
8
receptor car
8
car activation
8
pathways including
8
including involved
8
microrna expression
8
car
7
bioinformatic analysis
4
analysis microrna
4

Similar Publications

Constitutive androstane receptor (CAR) is a xenosensor that is almost exclusively expressed in the liver. Studies in rodents suggest an oncogenic role for CAR in liver cancer, but its role in human liver cancer is unclear. We aimed to investigate the functional roles of CAR in human liver cancer with a focus on the liver cancer stem cells.

View Article and Find Full Text PDF

Contradictory Role of Gadd45β in Liver Diseases.

J Cell Mol Med

December 2024

Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

There are three homologous proteins (α, β and γ) in the growth arrest and DNA damage 45 (Gadd45) family. These proteins act as cellular responders to physiological and environmental stimuli. Gadd45β plays a significant role in the pathogenesis of liver diseases.

View Article and Find Full Text PDF

Development of BODIPY FL SNS 032 as a Versatile Probe for Constitutive Androstane Receptor and Multiple Kinases.

ACS Med Chem Lett

November 2024

Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 1000, Memphis, Tennessee 38105, United States.

Article Synopsis
  • - The human constitutive androstane receptor (hCAR) is important for regulating how the body breaks down foreign substances, but a method for studying its binding with various compounds was needed.
  • - Researchers identified the compound SNS-032 and its derivative THAL-SNS-032 as candidates that bind to hCAR, leading to the development of a fluorescent probe called BODIPY FL SNS-032 that can effectively measure these interactions.
  • - BODIPY FL SNS-032 not only binds strongly to hCAR (with a binding affinity of around 300 nM) but also has significant binding affinities to various kinases, making it a useful tool for studying both hCAR and kinase function.
View Article and Find Full Text PDF

Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney.

Eur J Drug Metab Pharmacokinet

November 2024

Changsha Research and Development Center on Obstetric and Gynecologic Traditional Chinese Medicine Preparation, NHC Key Laboratory of Birth Defects Research, Prevention and Treatment, Hunan Provincial Maternal and Child Health Care Hospital, No. 53 Xiangchun Road, Kaifu District, Changsha, 410008, Hunan, China.

Background And Objectives: Hypertensive nephropathy (HN) has become one of the main causes of end-stage renal disease. Drug combination therapy is a common clinical treatment for HN. However, the impact of HN on drug-metabolizing enzymes and transporters, which may lead to drug-drug interactions (DDIs) and even trigger toxic side effects, remains unclear.

View Article and Find Full Text PDF

[Novel Regulatory Mechanisms for Expression of Drug Metabolism-related Factors].

Yakugaku Zasshi

November 2024

Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University.

Interindividual differences in the expression and activity of drug-metabolizing enzymes, including cytochrome P450, UDP-glucuronosyltransferase, and esterases, cause variability of therapeutic effectiveness and side effects during drug treatment. Conventional research has focused on transcriptional regulation by transcription factors and nuclear receptors such as aryl hydrocarbon receptor, pregnane X receptor (PXR), constitutive androstane receptor, and hepatocyte nuclear factor 4α, as the major mechanisms causing the differences in the expression of drug-metabolizing enzymes. Recently, we have revealed that adenosine-to-inosine RNA editing and methylation of adenosine at the N position on RNA, two major types of posttranscriptional modification, play a pivotal role in the regulation of drug metabolism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!